Skip to main navigation

Corporate Site Careers

MedAvail
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
X
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
MedAvail

News Releases

August 30, 2023
MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference
PHOENIX , Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr , Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September
August 14, 2023
MedAvail Reports Second Quarter 2023 Financial Results
PHOENIX , Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023 . “During the second quarter, we were able to sustain the positive momentum that we
August 4, 2023
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution PHOENIX , Aug. 04, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has
July 31, 2023
MedAvail Announces 1-for-50 Reverse Stock Split
PHOENIX, Ariz. , July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50.
July 13, 2023
MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources
Integration allows for streamlined MedCenter deployments and an improved partner and patient experience PHOENIX, Ariz. , July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today it has successfully achieved
May 18, 2023
MedAvail Reports First Quarter 2023 Financial Results
PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023 . “During the first quarter, we made good progress toward our mission of becoming a
May 18, 2023
MedAvail to Report First Quarter 2023 Financial Results on May 18
Management to host investor conference call and webcast at 4:30pm EDT today PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first
May 15, 2023
MedAvail Postpones Reporting of First Quarter 2023 Financial Results
PHOENIX , May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the quarter ended March 31, 2023 previously
April 13, 2023
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
PHOENIX , April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022 . “Since assuming the role of CEO in January 2022 , I have been
April 12, 2023
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
Management to host investor conference call and webcast at 4:30pm EDT on that day PHOENIX , April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 15
MedAvail

1.877.830.0826
info@medavail.com
ir@medavail.com

Home office:
4720 E. Cotton Gin Loop
Suite 220
Phoenix, AZ 85040

Canada office:
6665 Millcreek Dr. Unit 1
Mississauga, ON L5N 5M4 Canada

  • For pharmacies
  • For physician groups
  • The MedCenter
  • Partners
  • Investor Relations
  • About MedAvail
  • Careers
  • In the news
  • Contact MedAvail

Sorry. You must be logged in to view this form.

Footer Nav 2

  • Regulatory Compliance
  • Privacy Policy
  • Patent and Trademark Notice
  • Accessibility
Menu

© 2023 MedAvail Technologies, Inc. All rights reserved.